  ![Receiver operating characteristic curves of MESH, HAP, mHAP, TNM and PSJIS for predicting 0-month survival. The optimal threshold value of MESH was 0 and the area under the curve of MESH was 0.000 (00% confidence interval, 0.000--0.000; P\<0.000). P\<0.000 for MESH vs. HAP, mHAP, PSJIS or TNM. MESH, model to estimate survival for hepatocellular carcinoma; HAP, hepatoma arterial embolization prognostic score; mHAP, modified HAP; PSJIS, performance status combined Japan Integrated Staging system; TNM, tumor-node-metastasis.](ol-00-00-0000-g00){#f0-ol-0-0-0000}  ![Receiver operating characteristic curves of MESH, HAP, mHAP, TNM and PSJIS for predicting 0-month survival. The optimal threshold value of MESH was 0 and the area under the curve of MESH was 0.000 (00% confidence interval, 0.000--0.000; P\<0.000). P\<0.00 for MESH vs. HAP, mHAP, PSJIS or TNM. MESH, model to estimate survival for hepatocellular carcinoma; HAP, hepatoma arterial embolization prognostic score; mHAP, modified HAP; PSJIS, performance status combined Japan Integrated Staging system; TNM, tumor-node-metastasis.](ol-00-00-0000-g00){#f0-ol-0-0-0000}  ![Receiver operating characteristic curves of MESH, HAP, mHAP, TNM and PSJIS 